Published in PLoS One on August 04, 2011
Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3. Arthritis Res Ther (2012) 1.46
Genetics of Borrelia burgdorferi. Annu Rev Genet (2012) 1.21
Understanding barriers to Borrelia burgdorferi dissemination during infection using massively parallel sequencing. Infect Immun (2013) 1.08
Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One (2013) 1.07
Climate change and Ixodes tick-borne diseases of humans. Philos Trans R Soc Lond B Biol Sci (2015) 1.00
Review of evidence for immune evasion and persistent infection in Lyme disease. Int J Gen Med (2013) 0.94
Detection of Borrelia burgdorferi sensu stricto ospC alleles associated with human lyme borreliosis worldwide in non-human-biting tick Ixodes affinis and rodent hosts in Southeastern United States. Appl Environ Microbiol (2012) 0.92
Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol (2015) 0.91
Population bottlenecks during the infectious cycle of the Lyme disease spirochete Borrelia burgdorferi. PLoS One (2014) 0.88
Explosive radiation of a bacterial species group. Evolution (2012) 0.88
Occurrence and transmission efficiencies of Borrelia burgdorferi ospC types in avian and mammalian wildlife. Infect Genet Evol (2013) 0.85
Evolutionary Aspects of Emerging Lyme Disease in Canada. Appl Environ Microbiol (2015) 0.83
Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis. PLoS One (2013) 0.82
Heterogeneity of Borrelia burgdorferi Sensu Stricto Population and Its Involvement in Borrelia Pathogenicity: Study on Murine Model with Specific Emphasis on the Skin Interface. PLoS One (2015) 0.81
Molecular Typing of Borrelia burgdorferi. Curr Protoc Microbiol (2014) 0.80
Borrelia burgdorferi Keeps Moving and Carries on: A Review of Borrelial Dissemination and Invasion. Front Immunol (2017) 0.80
Toward a better understanding of European lyme neuroborreliosis. Clin Infect Dis (2013) 0.77
Invasive potential of Borrelia burgdorferi sensu stricto ospC type L strains increases the possible disease risk to humans in the regions of their distribution. Parasit Vectors (2014) 0.76
Homogeneous Inflammatory Gene Profiles Induced in Human Dermal Fibroblasts in Response to the Three Main Species of Borrelia burgdorferi sensu lato. PLoS One (2016) 0.75
Analysis of gene diversity in subdivided populations. Proc Natl Acad Sci U S A (1973) 26.31
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01
Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep (1997) 10.41
Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature (2010) 6.55
Beyond predictions: biodiversity conservation in a changing climate. Science (2011) 5.24
The clinical evolution of Lyme arthritis. Ann Intern Med (1987) 5.02
Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics (1999) 3.46
Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun (1999) 3.41
ospC diversity in Borrelia burgdorferi: different hosts are different niches. Genetics (2004) 2.97
Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the Northeastern United States. Genetics (2002) 2.92
Empirical Relationships between Species Richness, Evenness, and Proportional Diversity. Am Nat (2001) 2.40
Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis (2008) 2.26
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg (2008) 1.82
Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLoS Biol (2008) 1.78
Evolution and distribution of the ospC Gene, a transferable serotype determinant of Borrelia burgdorferi. MBio (2010) 1.55
Improving the yield of blood cultures from patients with early Lyme disease. J Clin Microbiol (2011) 1.22
A modest model explains the distribution and abundance of Borrelia burgdorferi strains. Am J Trop Med Hyg (2006) 1.16
Uncoordinated phylogeography of Borrelia burgdorferi and its tick vector, Ixodes scapularis. Evolution (2010) 1.15
Genetic diversity of Borrelia burgdorferi sensu stricto in Peromyscus leucopus, the primary reservoir of Lyme disease in a region of endemicity in southern Maryland. Appl Environ Microbiol (2006) 1.14
Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis. Arthritis Rheum (2009) 1.02
Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States. Clin Infect Dis (2009) 0.94
Syphilitic arthritis and osteitis. Rheum Dis Clin North Am (1993) 0.88
Human brain microvascular endothelial cell traversal by Borrelia burgdorferi requires calcium signaling. Clin Microbiol Infect (2009) 0.86
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Lyme borreliosis. Lancet (2011) 4.81
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79
Subjective symptoms after treatment of early Lyme disease. Am J Med (2010) 3.22
Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect Immun (2003) 3.19
Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis (2003) 3.18
Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88
Common misconceptions about Lyme disease. Am J Med (2013) 2.84
Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75
MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 2.67
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun (2010) 2.50
Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle. Mol Microbiol (2007) 2.32
Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis (2008) 2.26
Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York. Clin Infect Dis (2011) 2.19
Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11
Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis (2002) 1.97
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg (2008) 1.82
Reinfection in patients with Lyme disease. Clin Infect Dis (2007) 1.81
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.75
Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis (2008) 1.71
An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med (2002) 1.69
Serologic markers of Lyme disease in children with autism. JAMA (2013) 1.67
Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62
Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study. Vector Borne Zoonotic Dis (2013) 1.59
Antibiotic treatment of animals infected with Borrelia burgdorferi. Clin Microbiol Rev (2009) 1.51
Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med (2012) 1.50
Electrical twitch-obtaining intramuscular stimulation in lower back pain: a pilot study. Am J Phys Med Rehabil (2004) 1.49
Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions. Mol Microbiol (2009) 1.45
Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45
Why has Borrelia burgdorferi not been transmitted by blood transfusion? Transfusion (2013) 1.42
Poly-ticks: Blue State versus Red State for Lyme disease. Lancet (2005) 1.42
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40
Interaction and transmission of two Borrelia burgdorferi sensu stricto strains in a tick-rodent maintenance system. Appl Environ Microbiol (2004) 1.38
Fitness variation of Borrelia burgdorferi sensu stricto strains in mice. Appl Environ Microbiol (2007) 1.36
Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol (2006) 1.34
Linear and circular plasmid content in Borrelia burgdorferi clinical isolates. Infect Immun (2003) 1.33
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29
Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis (2011) 1.24
Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol (2003) 1.24
Improving the yield of blood cultures from patients with early Lyme disease. J Clin Microbiol (2011) 1.22
Bartonella spp. transmission by ticks not established. Emerg Infect Dis (2010) 1.19
Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol (2009) 1.18
Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome. Clin Immunol (2011) 1.18
Borrelia burgdorferi gene expression profiling with membrane-based arrays. Methods Enzymol (2002) 1.16
Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl Environ Microbiol (2008) 1.16
2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test. Clin Infect Dis (2010) 1.15
Borrelia burgdorferi bba74 is expressed exclusively during tick feeding and is regulated by both arthropod- and mammalian host-specific signals. J Bacteriol (2009) 1.14
Impaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice. FEMS Microbiol Lett (2004) 1.13
Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States. Emerg Infect Dis (2014) 1.13
Comparative transcriptional profiling of Borrelia burgdorferi clinical isolates differing in capacities for hematogenous dissemination. Infect Immun (2005) 1.11
Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol (2002) 1.11
A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr (2005) 1.10
Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. Diagn Microbiol Infect Dis (2012) 1.10
Microbiologic evaluation of patients from Missouri with erythema migrans. Clin Infect Dis (2005) 1.10
Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin Vaccine Immunol (2011) 1.09
Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect Immun (2004) 1.08
MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis (2013) 1.08
Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One (2013) 1.07
Borrelia burgdorferi requires glycerol for maximum fitness during the tick phase of the enzootic cycle. PLoS Pathog (2011) 1.06
Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease. Clin Infect Dis (2008) 1.03
Real-time PCR for simultaneous detection and quantification of Borrelia burgdorferi in field-collected Ixodes scapularis ticks from the Northeastern United States. Appl Environ Microbiol (2003) 1.02
Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status. J Clin Microbiol (2002) 1.02
Identification and molecular characterization of a cyclic-di-GMP effector protein, PlzA (BB0733): additional evidence for the existence of a functional cyclic-di-GMP regulatory network in the Lyme disease spirochete, Borrelia burgdorferi. FEMS Immunol Med Microbiol (2009) 1.01
Stage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation. Mol Microbiol (2014) 1.00
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin Diagn Lab Immunol (2005) 0.99
Erythromycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother (2002) 0.98
Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis (2012) 0.98
Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines. Infect Immun (2014) 0.97
The amber theory of Lyme arthritis: initial description and clinical implications. Clin Rheumatol (2012) 0.97
Borrelia burgdorferi BBA74, a periplasmic protein associated with the outer membrane, lacks porin-like properties. J Bacteriol (2006) 0.95
Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States. Clin Infect Dis (2009) 0.94
Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice. Antimicrob Agents Chemother (2002) 0.94
A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis (2013) 0.93
Borrelia burgdorferi vlsE antigenic variation is not mediated by RecA. Infect Immun (2008) 0.93
Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis (2011) 0.92
Oral doxycycline for neuroborreliosis. Lancet Neurol (2008) 0.92
BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease. Clin Vaccine Immunol (2010) 0.91
CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA. Emerg Infect Dis (2013) 0.91
Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease. Clin Diagn Lab Immunol (2005) 0.89
Hepatitis in association with rickettsialpox. Vector Borne Zoonotic Dis (2008) 0.89
Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design. Vector Borne Zoonotic Dis (2012) 0.89
Pattern of proinflammatory cytokine induction in RAW264.7 mouse macrophages is identical for virulent and attenuated Borrelia burgdorferi. J Immunol (2008) 0.89
Vertical transmission of Babesia microti, United States. Emerg Infect Dis (2012) 0.88